A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21

Condition:   Malaria, Plasmodium Falciparum Intervention:   Biological: Matrix-M with RH5.2 VLP and/or R21 Sponsors:   University of Oxford;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Medical Research Council Unit The Gambia at the LSHTM (MRCG) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials